ATE6937T1 - Hybridprotein gegen geschwuelste und verfahren zu seiner herstellung. - Google Patents
Hybridprotein gegen geschwuelste und verfahren zu seiner herstellung.Info
- Publication number
- ATE6937T1 ATE6937T1 AT80301111T AT80301111T ATE6937T1 AT E6937 T1 ATE6937 T1 AT E6937T1 AT 80301111 T AT80301111 T AT 80301111T AT 80301111 T AT80301111 T AT 80301111T AT E6937 T1 ATE6937 T1 AT E6937T1
- Authority
- AT
- Austria
- Prior art keywords
- moiety
- sub
- fragment
- antitumor
- indicates
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
- C07K16/3061—Blood cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
- A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
- A61K47/6811—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin
- A61K47/6817—Toxins
- A61K47/6829—Bacterial toxins, e.g. diphteria toxins or Pseudomonas exotoxin A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6889—Conjugates wherein the antibody being the modifying agent and wherein the linker, binder or spacer confers particular properties to the conjugates, e.g. peptidic enzyme-labile linkers or acid-labile linkers, providing for an acid-labile immuno conjugate wherein the drug may be released from its antibody conjugated part in an acidic, e.g. tumoural or environment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/55—Fab or Fab'
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/55—Fusion polypeptide containing a fusion with a toxin, e.g. diphteria toxin
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/866—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving immunoglobulin or antibody fragment, e.g. fab', fab, fv, fc, heavy chain or light chain
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Cell Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP4191979A JPS55136235A (en) | 1979-04-09 | 1979-04-09 | Antitumor protein complex and its preparation |
EP80301111A EP0017507B1 (de) | 1979-04-09 | 1980-04-08 | Hybridprotein gegen Geschwülste und Verfahren zu seiner Herstellung |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE6937T1 true ATE6937T1 (de) | 1984-04-15 |
Family
ID=12621650
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT80301111T ATE6937T1 (de) | 1979-04-09 | 1980-04-08 | Hybridprotein gegen geschwuelste und verfahren zu seiner herstellung. |
Country Status (9)
Country | Link |
---|---|
US (1) | US4638049A (de) |
EP (1) | EP0017507B1 (de) |
JP (1) | JPS55136235A (de) |
AT (1) | ATE6937T1 (de) |
AU (1) | AU533861B2 (de) |
DE (1) | DE3067313D1 (de) |
FI (1) | FI801108A (de) |
HU (1) | HU184736B (de) |
IL (1) | IL59727A (de) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5616417A (en) * | 1979-07-19 | 1981-02-17 | Teijin Ltd | Antitumor protein complex and its preparation |
JPS5686121A (en) * | 1979-12-14 | 1981-07-13 | Teijin Ltd | Antitumor proten complex and its preparation |
EP0044167A3 (de) * | 1980-07-14 | 1982-04-21 | The Regents Of The University Of California | Durch einen Antikörper gerichtetes zytotoxisches Mittel |
JPS57106626A (en) * | 1980-12-22 | 1982-07-02 | Teijin Ltd | Cytotoxic protein complex and its preparation |
JPS57106625A (en) * | 1980-12-22 | 1982-07-02 | Teijin Ltd | Cytotoxic protein complex and its preparation |
FI820020L (fi) * | 1981-01-12 | 1982-07-13 | Lilly Industries Ltd | Immunoglobulinkonjugater |
SE8102194L (sv) * | 1981-04-06 | 1982-10-07 | Pharmacia Ab | Terapeutiskt aktiv organisk forening och farmaceutisk beredning innehallande denna |
JPS5843926A (ja) * | 1981-09-08 | 1983-03-14 | Suntory Ltd | 選択性制癌剤 |
US4664911A (en) * | 1983-06-21 | 1987-05-12 | Board Of Regents, University Of Texas System | Immunotoxin conjugates employing toxin B chain moieties |
US5260203A (en) * | 1986-09-02 | 1993-11-09 | Enzon, Inc. | Single polypeptide chain binding molecules |
JPS63290824A (ja) * | 1987-05-22 | 1988-11-28 | Sumitomo Chem Co Ltd | ウイルス感染症治療剤 |
US5241078A (en) * | 1988-06-14 | 1993-08-31 | Cetus Oncology | Coupling agents and sterically hindered disulfide linked conjugates prepared therefrom |
CA2082265A1 (en) * | 1990-05-07 | 1991-11-08 | Chien-Hsing Chang | Method for radiolabeling monovalent antibody fragments |
US5612034A (en) * | 1990-10-03 | 1997-03-18 | Redcell, Inc. | Super-globuling for in vivo extended lifetimes |
WO2007106435A2 (en) * | 2006-03-10 | 2007-09-20 | University Of California | Cleavable vaccines compositions and methods of making and using the same |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4201770A (en) * | 1973-05-07 | 1980-05-06 | The Ohio State University | Antigenic modification of polypeptides |
US4160018A (en) * | 1973-06-25 | 1979-07-03 | Bjorklund Knut B | Stabilized cancer associated polypeptide antigen and preparation thereof |
DE2456224A1 (de) * | 1974-11-28 | 1976-08-12 | Karl Dr Med Theurer | Verwendung von nativen antikoerpern oder von antikoerper-fragmenten mit kovalent gebundenen oder konjugierten zytostatisch und/bzw. oder zytotoxisch wirkenden substanzen fuer die krebstherapie |
IL47372A (en) * | 1975-05-27 | 1979-10-31 | Yeda Res & Dev | Fab'dimers bound to daunomycin or adriamycin,their preparation and pharmaceutical compositions containing same |
US4174385A (en) * | 1976-10-08 | 1979-11-13 | Robert Reid | Method of identification of surface proteins of cancer cells, clinical test and method of immunization |
DE2862449D1 (en) * | 1977-08-22 | 1984-11-22 | Nat Res Dev | Macromolecular covalent conjugates, methods for preparing and pharmaceutical compositions containing them |
JPS54145655A (en) * | 1978-05-06 | 1979-11-14 | Asahi Chem Ind Co Ltd | Imidate derivative and its salt |
-
1979
- 1979-04-09 JP JP4191979A patent/JPS55136235A/ja active Granted
-
1980
- 1980-03-28 IL IL59727A patent/IL59727A/xx unknown
- 1980-04-04 US US06/137,193 patent/US4638049A/en not_active Expired - Lifetime
- 1980-04-08 AU AU57228/80A patent/AU533861B2/en not_active Expired - Fee Related
- 1980-04-08 DE DE8080301111T patent/DE3067313D1/de not_active Expired
- 1980-04-08 EP EP80301111A patent/EP0017507B1/de not_active Expired
- 1980-04-08 FI FI801108A patent/FI801108A/fi not_active Application Discontinuation
- 1980-04-08 AT AT80301111T patent/ATE6937T1/de not_active IP Right Cessation
- 1980-04-09 HU HU80851A patent/HU184736B/hu unknown
Also Published As
Publication number | Publication date |
---|---|
HU184736B (en) | 1984-10-29 |
EP0017507A2 (de) | 1980-10-15 |
DE3067313D1 (en) | 1984-05-10 |
AU533861B2 (en) | 1983-12-15 |
JPH02328B2 (de) | 1990-01-08 |
IL59727A (en) | 1983-03-31 |
JPS55136235A (en) | 1980-10-23 |
US4638049A (en) | 1987-01-20 |
EP0017507A3 (en) | 1981-08-05 |
FI801108A (fi) | 1980-10-10 |
AU5722880A (en) | 1980-10-16 |
IL59727A0 (en) | 1980-06-30 |
EP0017507B1 (de) | 1984-04-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE7574T1 (de) | Antitumor-proteinhybrid und verfahren zu seiner herstellung. | |
ATE6937T1 (de) | Hybridprotein gegen geschwuelste und verfahren zu seiner herstellung. | |
ATE14023T1 (de) | Einen monoklonalen antikoerper produzierende hybridzellinie, antikoerper und verfahren zu seiner herstellung, diesen antikoerper enthaltende therapeutische zusammensetzung und deren diagnostische und therapeutische verwendungen. | |
GB1520522A (en) | 16-methyleneprostaglandins | |
FR2354327A1 (fr) | Diglycidyl hydantoines et leurs applications comme matieres resineuses | |
JPS55149331A (en) | Modifier for synthetic resin | |
BG35746A3 (en) | Method for preparing 1- cyclohexenylmethylpyrolidines | |
JPS5616417A (en) | Antitumor protein complex and its preparation | |
FI830397A0 (fi) | Foerfarande foer framstaellning av imidazolidinderivat | |
FR2514006B1 (de) | ||
ES478706A1 (es) | Un metodo para producir un compuesto desmetilmaitansinoide. | |
YU25699A (sh) | Novi derivati eritromicina, postupak za njihovu izradu i njihova primena | |
FR2356700A1 (fr) | Pigments bis-azomethiniques metalliferes complexes | |
GB1524678A (en) | Organosilicon compounds | |
GB1512179A (en) | Thionobenzenephosphonic acid 0,0-diesters and their use as insecticides and acaricides | |
ES8301493A1 (es) | Procedimiento para preparar polieteres sililados | |
GB1482388A (en) | Method of producing 6-beta-amidinopenicillanic acid derivatives | |
GB1529463A (en) | Pharmaceutical compositions | |
BG36200A3 (en) | Method for preparing vinblastine- 3- (2- chlorethyl)- carboxymides | |
IT7849988A0 (it) | Pero procedimento per produrre ghise in pani di composizione controllata apartire da minerali ferrosi di recu | |
ES486995A1 (es) | Un procedimiento para la preparacion de una b-lactama | |
DE3468871D1 (de) | Pesticidal nitromethylene derivates | |
JPS5473785A (en) | 2-alkyl-4-trimethyl-5-fluorouracil | |
TH14773A (th) | อนุพันธ์ของอีริโธรมัยซิน | |
ES403886A1 (es) | Procedimiento de preparacion de amidas del acido (trimetoxi-3,4,5)cinemico. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |